TNF Pharmaceuticals, Inc.
TNFA
$0.0625
-$0.0126-16.78%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.90% | -19.50% | -483.98% | -339.60% | -34.82% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.43% | 619.16% | 256.18% | 261.63% | 1,938.61% |
| Change in Net Operating Assets | -171.82% | -156.38% | -193.42% | 1,611.11% | 463.91% |
| Cash from Operations | 4.34% | 9.86% | 32.04% | 24.87% | 33.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 998.25% | -130.99% | -430.56% | 9.42% | 85.86% |
| Cash from Investing | 998.25% | -130.99% | -430.56% | 9.42% | 85.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -4.67% | -4.67% | -4.67% |
| Repurchase of Preferred Stock | 100.00% | 100.00% | 17.97% | -- | -- |
| Total Dividends Paid | 50.50% | 50.50% | -82.17% | -- | -- |
| Other Financing Activities | 146.90% | 146.90% | 100.00% | -- | -- |
| Cash from Financing | -101.41% | 554.07% | -4.99% | -17.25% | -45.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.29% | -510.78% | -229.81% | 7,873.91% | 143.29% |